Maponos Therapeutics

Biotechnology Research • Chicago, Illinois, United States • 1-10 Employees

Company overview

Headquarters	Chicago, Illinois, United States
Website	maponostherapeutics.com
NAICS	541714
Employees	1-10
Socials

Key Contact at Maponos Therapeutics

Ai-Hong Zhang

Early R&D Director

About Maponos Therapeutics

Maponos Therapeutics is a cellular therapy company dedicated to development of revolutionary therapeutics for different human diseases, including tissue fibrosis and cancers. We are focused on the cutting-edge technology and discovery of multiple types of cells for innovative and curative treatments. The company was recently cofounded by three faculty members who are affiliated with the University of Chicago School of Medicine and are among leaders in their respective fields. The company licensed the technologies and know-hows from the University of Chicago. The mission of Maponos Therapeutics is to address the unmet medical need by creating innovative treatment with next-generation cell therapeutics.

Maponos Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Maponos Therapeutics has never raised funding before.